| 06 Dec, 10:16 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Dec, 10:14 am | — | … | Biocon Limited has informed the Exchange regarding Outcome of Board Meeting held on December 06, 2025. | nse |
| 06 Dec, 10:12 am | — | … | Biocon Ltd - 532523 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI Listing Regulations, 2015 | bse |
| 05 Dec, 06:05 pm | — | … | Biocon Limited has informed the Exchange regarding 'Notification to Stock Exchanges'. | nse |
| 03 Dec, 10:53 pm | — | … | Biocon Ltd - 532523 - Board Meeting Intimation for Intimation Of Board Meeting | bse |
| 02 Dec, 09:10 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Dec, 09:04 am | — | … | Biocon Limited has informed the Exchange regarding a press release dated December 02, 2025, titled "Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World®". | nse |
| 27 Nov, 08:23 am | — | … | Biocon Limited has informed the Exchange regarding 'Company Statement'. | nse |
| 19 Nov, 09:07 am | — | … | Biocon Limited has informed the Exchange about Notification to Stock Exchanges | nse |
| 18 Nov, 05:14 pm | — | … | Biocon Ltd - 532523 - Transcript Of Earnings Call Q2 FY26 | bse |
| 18 Nov, 04:58 pm | — | … | Biocon Limited has informed the Exchange about Transcript | nse |
| 14 Nov, 08:30 am | — | … | Biocon Limited has informed the Exchange about Rumour Verification - Regulation 30(11) | nse |
| 13 Nov, 10:11 am | — | … | Biocon Ltd - 532523 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | bse |
| 12 Nov, 03:17 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 12 Nov, 03:07 pm | — | … | Biocon Limited has informed the Exchange about Link of Recording | nse |
| 12 Nov, 08:36 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Nov, 08:25 am | — | … | Biocon Limited has informed the Exchange about Investor Presentation | nse |
| 11 Nov, 08:58 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 11 Nov, 08:57 pm | — | … | Monitoring Agency Report for the quarter ended on September 30, 2025 | nse |
| 11 Nov, 08:54 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Raising of Funds | bse |
| 11 Nov, 08:51 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Nov, 08:49 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | bse |
| 11 Nov, 08:47 pm | — | … | Biocon Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Biocon Q2FY26 Operating Revenue at Rs 4,296 Cr, Up 20% EBITDA at Rs 928 crore; Up 29%; PBT (before exceptional items) at Rs 183 Cr, Up 153%". | nse |
| 11 Nov, 08:42 pm | — | … | Biocon Limited has informed the Exchange about issue of Securities through of Issuance of Commercial Papers | nse |
| 11 Nov, 08:39 pm | — | … | Biocon Limited has informed the Exchange about Agreements | nse |
| 11 Nov, 08:38 pm | — | … | Biocon Ltd - 532523 - Outcome Of Board Meeting Held On November 11, 2025 | bse |
| 11 Nov, 08:37 pm | — | … | Biocon Limited has informed the Exchange about outcome of the Board Meeting-Early full redemption of Non-Convertible Debentures | nse |
| 11 Nov, 08:34 pm | — | … | Biocon Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2025. | nse |
| 11 Nov, 08:29 pm | — | … | Biocon Ltd - 532523 - Financial Results For Quarter And Half Year Ended 30 September, 2025 | bse |
| 11 Nov, 08:28 pm | — | … | Biocon Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 08 Nov, 06:00 pm | — | … | Biocon Limited has informed the Exchange about Notification to Stock Exchange | nse |
| 06 Nov, 05:42 pm | — | … | Biocon Ltd - 532523 - Update on board meeting | bse |
| 30 Oct, 08:39 pm | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 30 Oct, 08:37 pm | — | … | Biocon Limited has informed the Exchange about Credit Rating | nse |
| 30 Oct, 03:47 pm | — | … | Biocon Limited has informed the Exchange regarding 'Intimation of change in status and name of step-down subsidiary of the Company'. | nse |
| 23 Oct, 06:34 pm | — | … | Biocon Limited has informed the Exchange about change in name of step-down subsidiaries of the Company | nse |
| 23 Oct, 08:13 am | — | … | Biocon Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "Biocon Biologics Receives Health Canada Approval for Yesintek and Yesintek I.V. (ustekinumab), a Biosimilar to Stelara®". | nse |
| 16 Oct, 03:50 pm | — | … | Biocon Limited has informed the Exchange regarding a press release dated October 16, 2025, titled "Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options". | nse |
| 11 Oct, 08:43 pm | — | … | Biocon Limited has informed the Exchange about Company Statement | nse |
| 09 Oct, 01:19 pm | — | … | Biocon Ltd - 532523 - Submission Of Copy Of Biocon India Limited Employees Welfare Trust Amendment Deed | bse |
| 09 Oct, 01:16 pm | — | … | Biocon Limited has informed the Exchange about General Updates | nse |
| 07 Oct, 08:05 am | — | … | Biocon Limited has informed the Exchange about Notification to Stock Exchanges | nse |
| 06 Oct, 07:54 pm | — | … | Biocon Ltd - 532523 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting | bse |
| 01 Oct, 08:10 pm | — | … | Biocon Limited has informed the Exchange regarding Outcome of Board Meeting held on October 01, 2025. | nse |
| 01 Oct, 08:09 pm | — | … | Biocon Ltd - 532523 - Board Meeting Outcome for Early Redemption Of Ncds | bse |
| 01 Oct, 09:01 am | — | … | Biocon Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Biocon Biologics Secures U.S. Market Entry Date for Bosaya and Aukelso , Denosumab Biosimilars". | nse |
| 01 Oct, 08:59 am | — | … | Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Sept, 11:27 pm | — | … | Biocon Ltd - 532523 - Board Meeting Intimation for Proposed Early Redemption Of Unlisted, Secured, Rated, Redeemable, Non-Convertible Debentures (Ncds). | bse |
| 25 Sept, 05:23 pm | — | … | Biocon Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | nse |
| 25 Sept, 05:15 pm | — | … | Biocon Ltd - 532523 - Announcement Under Regulation 30 - Receipt Of Show Cause Notice | bse |